ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · Real-Time Price · USD
9.47
+0.06 (0.64%)
Aug 14, 2026, 4:00 PM EDT - Market closed
ADMA Biologics Market Cap
ADMA Biologics has a market cap or net worth of $2.12 billion as of August 14, 2026. Its market cap has decreased by -48.32% in one year.
Market Cap
2.12B
Enterprise Value
2.19B
1-Year Change
-48.32%
Ranking
Category
Stock Price
$9.47
ChartMarket Cap Chart
Since October 17, 2013, ADMA Biologics's market cap has increased from $50.20M to $2.12B, an increase of 4,125.37%. That is a compound annual growth rate of 33.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 2.12B | -51.14% |
| Dec 31, 2025 | 4.34B | 7.08% |
| Dec 31, 2024 | 4.05B | 296.92% |
| Dec 29, 2023 | 1.02B | 33.78% |
| Dec 30, 2022 | 763.50M | 176.53% |
| Dec 31, 2021 | 276.10M | 49.73% |
| Dec 31, 2020 | 184.40M | -22.29% |
| Dec 31, 2019 | 237.30M | 114.17% |
| Dec 31, 2018 | 110.80M | -12.41% |
| Dec 29, 2017 | 126.50M | 91.67% |
| Dec 30, 2016 | 66.00M | -23.70% |
| Dec 31, 2015 | 86.50M | -16.67% |
| Dec 31, 2014 | 103.80M | 44.37% |
| Dec 31, 2013 | 71.90M | 43.23% |
| Oct 17, 2013 | 50.20M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biohaven | 2.24B |
| Harmony Biosciences Holdings | 2.24B |
| Ocular Therapeutix | 2.22B |
| Mesoblast | 2.18B |
| Nuvation Bio | 2.14B |
| Septerna | 2.11B |
| Vera Therapeutics | 2.08B |
| Kardigan | 2.04B |